BRAIZON THERAPEUTICS
Live / Registered — Registered (as of 06 Apr 2021)
What this means for you
Registered since 06 Apr 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 06 Apr 2027, and its filing window is open now).
Record
- Serial number
- 88328860
- Registration number
- 6316214
- Mark type
- Design + words
- Filed
- 06 Mar 2019
- Published for opposition
- 09 Jul 2019
- Registered
- 06 Apr 2021
- Next maintenance filing
- §8 declaration of use, due by 06 Apr 2027 (grace period to 06 Oct 2027)
- Attorney of record
- M. Scott Alprin
Goods and services
- Class 042 — Scientific and technological services: Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff
Owner
- Braizon Therapeutics, Inc., Bunkyo-ku, Tokyo, JP
- Braizon Therapeutics, Inc., Bunkyo-ku, Tokyo, JP
- Braizon Therapeutics, Inc., Bunkyo-ku, Tokyo, JP
Prosecution history
- 06 Apr 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Mar 2021 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 03 Nov 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 03 Nov 2020 — FINAL REFUSAL E-MAILED
- 03 Nov 2020 — SU - FINAL REFUSAL - WRITTEN
- 29 Oct 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Oct 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Oct 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Oct 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Oct 2020 — NON-FINAL ACTION E-MAILED